I. Introduction
Radiotherapy is the most routinely used conventional cancer treatment. Since, studies suggest that during this procedure, ionizing gamma radiation discharged through multiple beams towards the targeted tumor area not only kill tumor cells but also damage the surrounding normal tissues (1, 2) . In order to avoid radiation induced damage to organs and tissues surrounding the tumor and at the same time efficiently sensitize and destroy tumor cells, small molecules derived from natural sources are in development (3, 4) .
Plant-derived small molecules have been reported to have diverse biological and pharmacological properties (5) . The small phyto-molecules like withaferin-A (from Withania somnifera), apigenin, kaempferol, anthocyanidin (from Solanum nigrum L); curcumin (from Curcuma longa), and berberine (from Tinospora cordifolia), glycyrrhizin (from Glycyrrhiza glabra), diallyl disulphide, diallyl trisulphide (from Allium sativum), and capsaicin (from Capsicum annuum) have been shown to accomplish chemo-sensitizing activities both in vitro and in vivo have been considered to overcome tumor resistance to chemotherapy and as radio-sensitizers to enhance the efficacy of therapeutic radiation (6) (7) (8) .
Predominantly all cytotoxic therapies are mediated by inducing apoptosis in tumor cells (9) . TRAIL besides inducing apoptosis is known to have anti-tumor activity, where it showed regression of tumor growth in SCID mouse upon systemic administration. Yet, cancer cells evade TRAIL-induced cytotoxic activity due to its rapid clearance from the system and also due to death receptor dysfunction certain tumor cells evade TRAILinduced apoptosis and become resistant to death signals (10, 31) . Plant-derived small molecules like Quercetin, curcumin, apigenin, Kaempferol, γ-Tocotrienol (γ-T3), diosgenin, anacardic acid have been reported to sensitize resistant tumor cells to TRAIL-induced cell death (11) (12) .
Tinospora cordifolia is one of the noncontroversial and extensively used herbs in Ayurvedic medicine. It belongs to family Menispermaceae. It is woody climber native to Western Ghats (13) . The plant has been reported to have immunomodulatory, anti-diabetic, anti-cancer and various medicinal properties and active components isolated from T. cordifolia are alkaloids, diterpenoid lactones, steroids, glycosides aliphatic compounds, polysaccharides (14, 16) . It has been shown that the polysaccharide fraction from t. cordifolia was found to be very effective in reducing the metastatic potential of B16F-10 melanoma cells (17) . The antiangiogenic and proapoptotic potential of T. cordifolia crude extract or hexane fraction respectively has been reported. (18, 16) . In our earlier studies, we have shown that the hexane fraction of T. cordifolia to be both antiangiogenic and pro-apoptotic, wherein it inhibits VEGF or MTA-1-mediated angiogenesis (19) . It also inhibits transcription factors like Snail, Twist, and Slug which are associated with the epithelial-to-mesenchymal transition, a key regulatory process of metastasis (20) .
The radioprotective property of Tinospora was first reported in 2002. The aqueous stem extract of Tinospora cordifolia exhibited free radical scavenging and metal chelation properties and thereby provided protection against ionizing radiation (21) . We have for the first time reporting the isolation of N-coumaroyl tyramine from T.cordifolia, earlier reports show that the compound has been isolated from A. chinense, C.fimbriata, E. racemose, I.turpethum and P. umbellatum (22, 23) . N-trans-p-coumaroyl tyramine has been reported to exhibit potent radical scavenging effects along with inhibitory activity against cell proliferation, platelet aggregation along with anti-oxidant effect. It also shows strong suppression against phagocytic response along with anti-microbial activity (24) .
Our preliminary study on the anti-angiogenic activity of hexane extract of T. cordifolia (TcHf) has shown that regular administration of 100µg for alternative days (11.42mg/kg b. w.) arrested tumor growth in EAT transplanted mice (16) . Therefore, the present study was undertaken to obtain an insight into N-Coumaroyl tyramine diacetate (N-CTD) induced sensitization of TRAIL-resistant cells to TRAIL induced apoptosis, besides its radioprotective effect reflecting on survival rate.
II. Materials And Methods

Preparation and purification of active Phyto-compound:
The stems of T.cordifolia were collected, dried and the active compound was prepared by solvent extraction and column purification as described (25) . In brief, the shade dried, coarsely powdered stems were subjected to solvent extraction based on their polarity. Extracts were evaporated by rotary evaporator. The hexane fraction having biological activity was subjected to thin layer and silica gel column chromatography, using hexane/chloroform/acetone (7:2:1) as the mobile phase. The fraction number 1 (F1) was collected and visualized under UV and extract was further analyzed for structure and molecular weight and was determined as N-coumaroyl tyramine diacetate (N-CTD). The 10mg of the active compound was dissolved in 1 ml DMSO and diluted further 10 times with phosphate buffered saline to make a final concentration of 1 μg/μl and used for subsequent experiments.
Cell viability Assay
In order to assess the sensitivity of the tumor cell lines, Kelly and HeLa cells to TRAIL a Trypan blue exclusion assay was done. Cells (1x10 3 ) were seeded onto 6 well plates and incubated overnight. The cells were either treated with N-CTD and human rTRAIL at different concentration for 12 hours or pre-treated with N-CTD (50µg) for 12h and then followed by treatment with different concentrations of rTRAIL at 5% CO2 in 37oC. The cells were collected by trypsinization and washed in PBS, stained with 0.2% trypan blue. The cell viability was determined by enumerating the cells using hemocytometer.
Analysis of Cell Viability by Flowcytometry
During the progression of tumor growth, determination of cell viability is a critical step when evaluating the physiological state of cells and flow cytometry provides a rapid and reliable method to quantify viable cells in a cell suspension. In Brief, HeLa cells (1 x 106) were either treated with NrTRAIL (50ng/ml) alone for 12 hours or pre-treated with N-CTD (50µg/ml) for 12hours and then followed by treatment with rTRAIL (50ng/ml) and harvested into FACS tubes. The cells were washed twice with PBS and pelleted by centrifugation at 300 x g for 5 minutes. The cells were resuspended in 100μl of 1x Flowcytometry Binding Buffer (HEPES with Cacl2). A staining solution was prepared by addition of 1x binding buffer, FIT-C Annexin V, and 7-AAD solutions. The staining solution was added to the cells, mixed gently and incubated for 5 minutes at 4 °C in the dark. Data was acquired for unstained cells, single-color positive controls and stained cells on a FACS Calibur and analyzed by CELLQuest 3.2 software (both BD Biosciences). The stop count was set on the viable cells from a dot-plot of forward scatter versus 7-AAD.
Radio sensitization and peritoneal angiogenesis assay.
Source of ionizing radiation: Gamma-irradiation was given by 60CO irradiation at a dose of 2Gy/min. EAT was transplanted into female Swiss albino mice. Briefly, EAT cells (5 x 106) were injected intraperitoneally (i.p) into mice (4 groups of mice, 5 in each group) and growth was recorded every day from the day of transplantation. On the 6th day after tumor inoculation, 100µg (2.85mg/ kg b.w) of N-CTD was injected (i.p). Control mice group with tumors were administered with PBS (i.p). Following 3-4 hours after injection, 2Gy irradiation was given to the dorsal region of the mice. (26) .
Record of Body weight, ascites volume, cell number
The growth of the tumor in vivo was assessed by taking the weight of the animal every day. On the 14th day, one animal in each group was sacrificed, to collect the tumor cells along with ascites fluid. The cells were centrifuged and the total ascites volume measured and the number of viable cells was counted by Trypan blue exclusion method.
Microvessel density counting:
The peritoneum of the respective animals was cut open and the inner lining of the peritoneal cavity was examined for extent of neovasculature and photographed. The sections were fixed in formaldehyde and paraffin embedded tissues of the peritoneum from EAT bearing mice either treated or untreated with N-CTD were taken and 5μm sections were prepared using automatic microtome and stained with Hematoxylin and Eosin. The images were photographed using a stereo-binocular microscope with CCD camera and blood vessels were counted. The Microvessel density (MVD) count of the sections was done by Hotspot method. The mean value of 10 most vascularized areas at X 40 field was considered as MVD for a sample.
CD31 Immunohistochemical staining:
During angiogenesis, CD31 mediated endothelial cell-cell interactions are involved. Hence, to check the effect of N-CTD and ionizing radiation peritoneum sections were processed as per the protocol supplied by the manufacturer (Santa Cruz Biotechnology, CA, USA). In brief, sections were dewaxed in xylene thrice for 5 min each. The sections were rehydrated in descending concentrations of ethanol (100% ethanol for 5 min, 95% for 2 min and 70% for 2 min) and washed in distilled water. Antigen retrieval was done by heating the sections at 95 0C for 15 min in a humidified atmosphere topped with 50mM sodium phosphate buffer. The sections were treated with 3% H2O2 in PBS to block endogenous peroxidase activity. They were blocked in blocking serum for 30 min to reduce the nonspecific binding and were incubated with anti-CD 31 (PECAM-1) antibodies for 2 hrs. Following PBS wash, slides were incubated with secondary antibody (biotinylated goat anti-mouse IgG -HRP) for 1 hr at room temperature. The slides were washed in PBS for 5 min and antigen and antibody complex was detected using a substrate (DAB, 100µl/section) for 5 min. The sections were washed thrice for 2 min in tap water and twice for 2 min in distilled water. Subsequently, the slides were counterstained with 2 % Hematoxylin for 30 sec and washed again in tap water thrice for 5 min each. The slides were dehydrated for 2 min each in 50% ethanol, 80% ethanol, and absolute alcohol. After xylene wash, the slides were mounted using Entellanmountant solution and the sections were scored using a stereo-binocular microscope and photographed.
III. Results
Differential effect of N-CTD and rTRAIL on Kelly and HeLa cells
The two cell lines (Kelly and HeLa cells) selected for the study are reported to be sensitive and resistant to TRAIL respectively. The data shown in (Fig 1A) clearly indicates that a dose response to either N-CTD or rTRAIL treatment shows a dose-dependent inhibition of cell viability. The TRAIL-resistant HeLa cells, when treated in a similar manner, did not respond and show a dose-dependent inhibition of cell viability ( Fig  1B) . Further, pre-treatment of HeLa cells to suboptimal doses of N-CTD (3.12µg/ml) for 12h prior to rTRAIL for 12h rendered HeLa cells sensitive to rTRAIL-induced cell death.
Synergistic effect of N-CTD and rTRAIL on cell viability.
Flow cytometric analysis using 7ADD showed growth inhibition in N-CTD and rTRAIL treated samples as seen in Fig 2A. Cell death was evident in N-CTD and rTRAIL alone treated cells but was significantly enhanced by 37% when treated in combination. This clearly indicates that N-CTD and rTRAIL can induce cell death individually, but a pre-treatment with N-CTD enhances the ability of rTRAIL to induce death in resistant cells.
N-CTD enhances the radioprotective survival in vivo.
To study the potential effect of low doses of N-CTD (2.85mg/kg b.w) along with low doses of radiation on the survival of EAT bearing mice, a survival study was planned. It was observed that the mice treated with N-CTD and radiation survived for over 50days as against to mice treated only with 2Gy radiation which survived for only 15days which were similar to tumor-bearing mice without treatment. The improved inhibition of proliferation was monitored by measuring the weight of the animals every day. A decrease in body weight in animals treated with N-CTD and radiation were observed in comparison to the increased body weight of the animals treated alone with radiation and a low dose of N-CTD on tumor bearing mice. It is indicative from this data that a low dose of N-CTD is capable of inducing radioprotection and enhances survivability (Fig. 3) .
N-CTD radiosensitizes tumor cells and inhibits peritoneal angiogenesis.
Further, the inhibition of angiogenesis and tumor cell proliferation was evident in peritoneal angiogenesis. The body weight, ascites volume, and the total tumor cell number count were decreased (Fig 4 A,  B, C) . A significant decrease in blood vessel formation was observed in the peritoneum of mice treated with single dose of N-CTD along with radiation as compared with that of mice treated with N-CTD and radiation alone (Fig 4D) . The effect of radiation on Average Microvessel density (MVD) count by Hotspot method and its modification by treatment with N-CTD has been depicted in (Fig 4E) . From the data, it is clearly evident that administration of single dose of N-CTD (2.85mg/kg b.w) decreased MVD compared to that of the untreated tumor bearing mice. N-CTD along with radiation further decreased the MVD. The endothelial cell marker CD31 showed significant decrease in the intensity of staining and also in the number of blood vessels indicating inhibition of vascularization by N-CTD upon radiation therapy (Fig 4F) 
IV. Discussion
Conventional cancer therapy like chemotherapy and radiation therapy have several disadvantages and limitations (27) . These therapies tend to induce time-dependent resistance in tumor cells (chemoresistance and radioresistance) and are cytotoxic to the surrounding normal cells with several side-effects which affect the normal functioning of organs. These therapies are also known to elicit immune-suppression and lead to physical changes which are emotionally challenging (28) . Several alternative therapies have been developed to overcome the side-effects and the resistance to conventional cancer therapy. However, the results are promising but they are seldom reported.
TRAIL-mediated apoptosis is a regulatory process which is evaded by the tumor cells during proliferation and resistance to apoptosis (29, 30) . To improve the therapeutic efficacy of any conventional therapies, they are strategically combined with death-regulating molecules like TRAIL or other novel small molecules to inhibit other tumor checkpoints like angiogenesis (31) (32) (33) . Harsha Raj et.al in their study have shown that anacardic acid sensitizes TRAIL resistant Hela cells to TRAIL-induced apoptosis by regulating MAPK, NF-kB and p53. Similarly, hexane fraction (TcHf) of T.cordifolia showed pro-apoptotic activity by inducing apoptosis mediated by caspases-3 activated DNase (Thippeswamy) . We in this study have reported that pre-treatment of TRAIL-resistant Hela cells by N-Coumaroyl tyramine diacetate induces TRAIL-mediated apoptosis and sensitizes the tumor cells to TRAIL-induced apoptosis. Flowcytometric analysis further proves the enhanced sensitizing effect of N-CTD to apoptosis in TRAIL-resistant cells. Understanding the mechanisms of combination therapy is necessary for the clinical development of small molecule-based drug delivery system combined with conventional therapy (34) .
The mechanism of radioprotection is processed by a various parallel mechanism of action a molecule induces (35) . The moment a cell is exposed to irradiation, a series of discrete reversible destructive processes are induced which can be blocked using therapeutic small molecules. The radioprotectant molecule is mechanistically classified as blockers of oxygen consumption, free radical scavengers, and DNA repair boosters, inhibitors of death signaling pathways, growth factors, blockers of radiation inflammation and chemotaxis, blockers of autocrine/paracrine pathways and keepers of genomic integrity (36) .
Sachin Raj et.al have reported the inhibition of MTA-1 mediated angiogenesis by the hexane fraction of T.cordifolia. Therefore, inhibition of peritoneal angiogenesis by N-CTD which involves reduction in number of proliferating cells, decrease in the number of blood vessels and improved survivability suggest that N-CTD sensitizes tumor cells to radiation and induces radio-protection. Since the radioprotective activity by small molecules is set to associate with inhibiting autocrine pathway, our studies show that N-Coumaroyl tyramine diacetate induces anti-angiogenesis by inhibiting peritoneal angiogenesis in-vivo, which is mediated by VEGF; this may have a role in its radioprotective effect. In conclusion, we have shown that N-Coumaroyl tyramine diacetate sensitizes death resistant tumor cells to TRAIL-mediated apoptosis. We also demonstrate that a very low dose of N-CTD can increase survival of tumor-bearing mice exposed to whole body irradiation along with inhibition of angiogenesis in-vivo. Therefore, N-Coumaroyl tyramine diacetate with significant therapeutic properties can be exploited to treat severe maladies of cancer.
FIGURES AND LEGENDS
Fig1. Effect of N-CTD and rTRAIL on cell viability.
Fig1(A, B) Kelly or HeLa cells were treated with various concentrations of N-CTD (3.12g -50g) or with rTRAIL (3.12ng -50ng) for 12 h. Cell viability was measured at the end of 12 h by trypan blue dye exclusion assay. (C), HeLa cells were sensitized with N-CTD (50g) for 12 h prior to treatment with rTRAIL (3.12ng -50ng) for 12 h. Cell viability was measured at the end of 24 h. Data represent mean ± SE. ** = significantly different from respective control; P < 0.05. EAT bearing mice which were treated with N-CTD extract (2.85mg/kg body weight) from 7 th day of tumor transplantation and irradiated with 2 Gy 60 CO radiation showed increased in the rate of survivability. EAT bearing mice were treated intraperitoneally with a single dose of N-CTD (100g/mouse i.e. 2.85mg/kg body weight) and 2Gy radiation. A single mouse was sacrificed in each group on the 15th day. A. The body weight of the mice was noted every day until the 15 th day. B. The volume of ascites formed was noted and C. Cell number was counted by trypan blue exclusion method. D. Photographs of the peritoneum were observed for the extent of vascularization. E. The peritoneum of untreated, N-CTD, radiation treated and as well as N-CTD with radiation were stained with H & E and observed for microvessel density. F. The sections were stained with CD31antibody. G. The microvessels were counted by Hot Spot method. The significant decrease in the microvessel density was observed in the sections from treated mice. Data represent mean ± SE. * = significantly different from respective control; P < 0.05.
